A profound transformation is taking place in therapeutic discovery, development, and delivery
As sequencing instruments accelerate, upstream chemistry and workflows struggle to keep up
Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines
The convergence of advanced life science technologies with powerful computational capabilities is driving a previously unimaginable scientific future built on automation. GEN asked four leaders who focus on the realization of this future to describe the trends they see for the coming year and beyond.
WuXi AppTec suggests “dynamic entities” require highly specialized analytical approaches
